The national law firm of Parker Waichman LLP has filed a lawsuit in U.S. District Court for the Northern District of Texas against DePuy Orthopaedics, Inc. and parent company Johnson & Johnson on behalf of a Michigan woman who allegedly suffered severe injuries from the metal-on-metal Pinnacle Hip Implant.
The lawsuit claims that the plaintiff had the Pinnacle hip device implanted on her left side in December 2006, and has since suffered adverse tissue reactions and pain. The lawsuit says that the Pinnacle device sheds high levels of toxic chromium and cobalt particles into the surrounding tissue and bloodstream which then accumulate and cause metallosis, pseudotumors, severe pain and discomfort as well as death of the local tissue and bone loss.
According to the lawsuit, the U.S Food and Drug Administration has received over 1,300 adverse event reports regarding the Pinnacle device, which is allegedly prone to premature failure and causes metallosis and cobalt toxicity. DePuy recalled more than 93,000 ASR devices in 2010, including the Pinnacle device.
Recently, the FDA ordered 21 metal-on-metal hip replacement device manufactures, including DePuy, to conduct post-market studies of their products regarding the shedding of metal debris. The Lancet medical journal published a study in March that found that recipients of metal-on-metal hip replacement devices face a 6.2 percent chance of needed the devices replaced within five years. In February, the British Medical Journal published that metal-on-metal hip replacement patients may be exposed to dangerously high levels of toxic and potentially cancer-causing metal from the failing hip implants.
Hundreds of federally filed Pinnacle hip device lawsuits have been consolidated to the Texas court under U.S. District Judge James Kinkeade. Parker Waichman LLP report that the FDAs Orthopaedic and Rehabilitation Devices Panel will meet on June 27 and 28 to discuss the pros and cons of the devices and make recommendations regarding their use.